10-Q: KindlyMD Pivots to Bitcoin, Reports Deepening Losses

KindlyMD announces a strategic merger with Nakamoto Holdings Inc. to adopt a Bitcoin treasury strategy, despite significant increases in net loss and operating expenses.

Summary

• KindlyMD reported a net loss of $2,413,787 for the three months ended June 30, 2025, a substantial increase from $1,319,653 for the same period in 2024.
• For the six months ended June 30, 2025, the net loss was $3,451,798, up from $1,601,979 in the prior year period.
• Revenues decreased by 36.1% to $408,527 for the three months ended June 30, 2025, and by 32.7% to $988,182 for the six months ended June 30, 2025, primarily due to a decrease in cash-pay patient care service pricing and the closing of the Bountiful location.
• Operating expenses surged by 67.0% to $2,800,018 for the three months and 61.2% to $4,421,414 for the six months ended June 30, 2025, driven by increased salaries and wages, and general and administrative costs.
• The company's cash and cash equivalents significantly increased to $6,024,604 as of June 30, 2025, from $2,273,624 at December 31, 2024, largely due to $9,216,420 in proceeds from warrant exercises.
• A merger agreement was entered into with Nakamoto Holdings Inc. on May 12, 2025, signaling a strategic shift to a Bitcoin-native holding company model.
• The merger involves issuing 22.3 million shares to Nakamoto stockholders at $1.12 per share and includes initial PIPE financing of approximately $511.7 million at $1.12 per share, and an additional $51.5 million PIPE financing at $5.00 per share.
• A secured convertible debenture of $200.0 million from YA II PN, Ltd. is also part of the financing strategy related to the merger.
• The company purchased 21 Bitcoin since May 12, 2025, holding digital assets valued at $2,250,566 as of June 30, 2025, and recognized an unrealized loss of $39,019 on these assets.
• Shareholders approved the merger and related capital raises via written consent on May 18, 2025, and June 19, 2025.

Sentiment

Score: 3

Explanation: The company's core operational financial performance is significantly negative, with widening losses and declining revenue. While a substantial capital raise and strategic pivot to a Bitcoin treasury strategy provide liquidity and potential speculative upside, this introduces high volatility and an unproven business model for a healthcare company. The massive dilution from the proposed share issuances at prices significantly below recent warrant exercise prices is a major concern for existing shareholders, leading to a cautious to negative sentiment.

Positives

• Cash and cash equivalents increased significantly to $6,024,604 as of June 30, 2025, from $2,273,624 at December 31, 2024, providing enhanced liquidity.
• Total stockholders' equity rose substantially to $8,966,888 as of June 30, 2025, from $2,568,310 at December 31, 2024.
• Proceeds from warrant exercises totaled $9,216,420, contributing significantly to cash reserves.
• Insurance reimbursements for patient care services increased by 153.1% for the three months and 150.9% for the six months ended June 30, 2025, indicating a successful shift towards insurance billing.
• Interest expense decreased by 98.8% for the three months and 97.3% for the six months ended June 30, 2025, due to a reduction in notes payable and amortization of debt discounts.
• The Board of Directors unanimously approved the merger with Nakamoto Holdings Inc. and associated financings, signaling strong internal support for the strategic pivot.
• Shareholder consent was obtained for the merger and related capital raises, streamlining the approval process.

Negatives

• Net loss significantly widened to $2,413,787 for the three months and $3,451,798 for the six months ended June 30, 2025, compared to the prior year periods.
• Total revenues decreased by 36.1% for the three months and 32.7% for the six months ended June 30, 2025, primarily due to lower cash-pay patient care service pricing and the closure of a location.
• Operating expenses increased substantially by 67.0% for the three months and 61.2% for the six months ended June 30, 2025, driven by higher salaries, wages, and general and administrative costs.
• An unrealized loss of $39,019 on digital assets was recognized for the three and six months ended June 30, 2025.
• The company reported material weaknesses in internal control over financial reporting as of June 30, 2025.
• Net cash used in operating activities increased to $2,776,302 for the six months ended June 30, 2025, indicating higher cash burn from operations.

Risks

• Ability to raise capital necessary to sustain anticipated operations and implement the business plan.
• Ability to implement the new business plan, particularly the Bitcoin treasury strategy.
• Ability to generate sufficient cash to ensure survival.
• Degree and nature of competition in both healthcare and digital asset sectors.
• Lack of diversification of the business plan, now heavily reliant on the Bitcoin strategy.
• General volatility of the capital markets and the establishment of a stable market for shares.
• Disruption in economic and financial conditions from global events.
• Risks associated with the implementation of the Bitcoin treasury strategy and its effects on the business.
• Potential termination fees of $2.5 million payable by either party if the merger agreement is terminated under certain circumstances, plus warrant exercise proceeds for KindlyMD.

Future Outlook

The company intends to pivot its strategic focus to a Bitcoin treasury strategy, viewing its Bitcoin holdings as long-term and expecting to accumulate more in the future. Future Bitcoin acquisitions are planned to be funded primarily through issuances of common stock and various fixed-income instruments. The company may also explore strategies to generate income or collateralize its Bitcoin holdings. The merger with Nakamoto Holdings Inc. is expected to close by November 14, 2025, subject to customary closing conditions. Management is focused on increasing cash reserves and liquidity through strategic transactions to meet obligations for at least the next 12 months and generate sustained cash flow thereafter.

Management Comments

• Management acknowledges the decrease in working capital and is focused on increasing cash reserves and liquidity in the near term through strategic transactions.
• KindlyMD management strives to look for opportunities to optimize revenue by increasing sales, improving margins, and controlling ongoing operating expenses.
• The company views its bitcoin holdings as long-term holdings and expects to continue to accumulate bitcoin in the future.
• The company intends to fund further bitcoin acquisitions primarily through issuances of common stock and a variety of fixed-income instruments, including debt, convertible notes and preferred stock.

Industry Context

KindlyMD is undergoing a significant and unusual strategic pivot, transitioning from a patient-first healthcare and healthcare data company to a Bitcoin-native holding company. This move diverges sharply from traditional healthcare industry trends, which typically focus on value-based care, digital health, and expanding patient services. By adopting a Bitcoin treasury strategy, KindlyMD is entering the volatile and speculative digital asset market, aligning itself more with companies like MicroStrategy that hold substantial Bitcoin reserves. This dual identity (healthcare provider and Bitcoin holder) is unique and introduces a complex risk profile, as the company's financial performance will now be heavily influenced by both healthcare operations and cryptocurrency market fluctuations. The shift also positions the company to potentially compete with or be compared to other Bitcoin-focused entities, rather than its traditional healthcare peers.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or industry benchmarks for its healthcare operations or its newly adopted Bitcoin treasury strategy, making a direct quantitative comparison challenging.
• In the healthcare sector, the reported decrease in overall revenue and increase in operating expenses suggest a performance below typical growth expectations for expanding medical service providers, although the increase in insurance reimbursements is a positive operational shift.
• For its new Bitcoin treasury strategy, the company's approach of acquiring and holding Bitcoin with proceeds from capital raises aligns with the strategy of companies like MicroStrategy, which has aggressively accumulated Bitcoin as a primary treasury reserve asset. However, KindlyMD's combination of a traditional healthcare business with a significant Bitcoin treasury is highly unconventional and lacks direct industry parallels for comprehensive performance assessment.

Corporate Governance

Legal Proceedings

• No existing or pending legal proceedings against the company were reported.
• The company is not involved as a plaintiff in any proceeding or pending litigation.

Related Party Transactions

• Advisory agreement with a financial advisory firm (the Representative) for $450,000, with $55,000 paid as of June 30, 2025, and $275,000 contingent on merger closing.
• Amended and Restated Engagement Agreement with a financial advisory firm (the Representative) for $500,000, payable as 30,000 restricted shares, with a cash true-up if market value is less than $500,000 after 6 months or merger closing.
• Non-interest bearing promissory note with BTC, Inc. for up to $1,750,000, with no proceeds drawn as of June 30, 2025.
• Marketing Agreement with BTC, Inc. (to be assigned to KindlyMD from Nakamoto) for issuance of up to 600,000,000 shares of common stock at $1.12 per share.

Stakeholder Impact

• **Shareholders**: Significant potential dilution from the issuance of hundreds of millions of new shares at $1.12 and $5.00 per share, which are below recent warrant exercise prices. The strategic pivot to Bitcoin introduces high volatility and speculative risk to their investment. Corporate governance changes may limit shareholder influence.
• **Employees**: Increased stock-based compensation and additional contracting labor, but also a significant strategic shift that may alter job roles and company culture.
• **Customers (Patients)**: Continued focus on patient-first healthcare and shift towards insurance billing may improve access and affordability, but the closure of the Bountiful location reduces physical access.
• **Creditors**: The company's improved cash position and planned capital raises enhance its ability to meet obligations, while the new convertible debenture introduces a new class of debt.

Next Steps

• Close the merger with Nakamoto Holdings Inc. by November 14, 2025.
• Register the resale of PIPE Shares with the SEC within 30 days after closing of the Merger Agreement and maintain effectiveness for up to three years.
• Implement the new Bitcoin treasury strategy, including further Bitcoin acquisitions.
• Continue efforts to optimize revenue, improve margins, and control operating expenses in healthcare operations.
• Address material weaknesses in internal control over financial reporting.

Key Dates

Recommendation

The company's core healthcare operations are deteriorating, evidenced by widening net losses and declining revenues, while operating expenses are surging. The strategic pivot to a Bitcoin treasury model, while providing a significant cash infusion from warrant exercises and planned capital raises, is highly speculative and introduces extreme volatility to the company's risk profile. Crucially, the proposed merger and associated PIPE financings involve the issuance of hundreds of millions of new shares at prices ($1.12 and $5.00) significantly below the recent warrant exercise price ($6.33) and the fair value of common stock issued for warrants ($6.33), indicating massive dilution for existing shareholders. This fundamental shift into a highly speculative asset class, coupled with severe operational losses and substantial dilution, makes the stock a high-risk proposition with significant downside for current investors.

Keywords

Bitcoin, Healthcare, Merger, Nakamoto Holdings, Digital Assets, SEC Filing, 10-Q, Financial Results, Capital Raise, PIPE Financing, Convertible Debenture, Corporate Governance, Risk Management, Patient Care Services, Medical Services